40 female patients with PCO and 50 healthy women matched to PCOS women as regard age and ethnic origin.

Evaluations, Diagnostic Self

Treatment Adherence

42,000 IU oral vitamin D per week and 500 mg calcium carbonate

cholecalciferol (vit D3)

Zagazig University

Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome

Impact of Vitamin D Supplementation on the Cardiometabolic Status and Androgen Profile in Women With Polycystic Ovary Syndrome: Placebo-Controlled Clinical Trial

change of LDL (mg/dl), TG (mg/dl) TG (mg/dl) ,(mg/dl)

Ovarian volume cm were evaluated by transvaginal ultrasound

Serum concentrations of 25(OH)-D( ng/ml )

antral follicular count were evaluated by transvaginal ultrasound

Nearmeen M.Rashad

ass.professor of internal medicine

he intervention group will receive VD Cholecalciferol (D2) 50,000 I.U once weekly for 12 weeks, followed by 50,000 I.U once every fortnight for 24 weeks with the Metformin treatment as prescribed by the physician whereas

control group will receive Metformin treatment during the study period.

Infertility, Female

Infertility

Vitamin D Deficiency

Vitamin D

Aga Khan University

Vitamin D and Polycystic Ovarian Syndrome

Efficacy of Vitamin D Supplementation and Metformin Compared to Metformin Alone for Improvement in Follicle Size of Infertile Females With Polycystic Ovary Syndrome: a Randomized Open Label Trial

Rehana Rehman

Associate Professor

Infertile females with Polycystic Ovarian Syndrome

hyperandrogenism/albumina

Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome

Vitamin D and Polycystic Ovarian Syndrome

Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)

THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOS

O mais completo banco de dados de ervas medicinais apoiado pela ciência